Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioTime Inc (NYSE MKT LLC:BTX)

3.25
Delayed Data
As of 11:05am ET
 +0.04 / +1.25%
Today’s Change
2.02
Today|||52-Week Range
4.01
-9.97%
Year-to-Date
No recent news for BioTime Inc.

Today’s Trading

Previous close3.21
Today’s open3.21
Day’s range3.21 - 3.26
Volume47,323
Average volume (3 months)265,840
Market cap$331.9M
Dividend yield--
Data as of 11:05am ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-7.27%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+34.19%
P/E ratio14.1
Price/Sales46.45
Price/Book10.79

Competitors

 Today’s
change
Today’s
% change
AGENAgenus Inc-0.03-0.79%
BOLDAudentes Therapeutic...-0.03-0.20%
BLCMBellicum Pharmaceuti...-0.29-2.29%
GERNGeron Corp-0.03-1.50%
Data as of 11:24am ET, 01/20/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$7.0M
Annual profit (last year)-$47.0M
Net profit margin-667.87%

Profile

Sector
Health Technology
Industry
Medical Specialties
Co-President, Co-CEO &
Director
Michael D. West
Co-President, Co-CEO &
Director
Aditya P. Mohanty
Corporate headquarters
Alameda, California

Forecasts


Search for Jobs